Health economic implications
We are interested in the health economic implications of genomic medicine interventions, particularly the impact on individuals and families of using genome sequencing for diagnosing rare diseases. Our work includes a focus on evaluating the psychometric performance of both standardised and bespoke patient- and caregiver-reported outcome measurement instruments.
Themes: Diagnosis and treatment, Risk and prevention, Evolving health system boundaries, Sustainability, Experiences of personalised medicine
Resources
Measuring the outcomes from genome sequencing for rare disease diagnosis: A health economist’s perspective
Watch hereThe changing landscape of genetics and insurance in the UK
See moreGenomics and insurance in the United Kingdom: increasing complexity and emerging challenges
See moreHERC Health Economics and Genomics Seminar 2024
Watch here